How do people make sense of the epiphanies when they experience them? Pexels

It might be just the right word from your boss. It might be a phone call with a trusted friend. Or it might be waking up one morning and just knowing. There's no way to predict what will spark an epiphany that changes the way you see the world. But their power can be so far-reaching, they often leave us wondering where on earth that brilliant idea came from — and how we can find more.

Studying the mental processes behind epiphanies is especially hard because these flashes of insight are usually linked with unconscious mental processing and incubation, often during time periods when one may not seem to be thinking about a problem at all. In this way, epiphanies seem to arrive effortlessly.

So how do people make sense of the epiphanies when they experience them? In a set of unprecedented studies, Rice Business professor Erik Dane set out to find answers, first examining people who'd experienced general epiphanies, then analyzing a set of accounts of work- and career-related epiphanies themselves.

The research

In his first study, Dane surveyed more than 500 randomly selected people to ask them about their experiences with epiphanies, which he defined as a sudden and abrupt insight and/or change in perspective that transforms the individual.

Subjects who said they'd experienced epiphanies reported what they'd been doing beforehand, the feelings and insight associated with the epiphany and how they thought they'd changed afterward. Interestingly, though this survey wasn't limited to career- or work-related epiphanies, 20 percent of the responses related directly to these topics.

In the second study, Dane interviewed 22 professionals, asking them about distinct work- or career-related epiphanies, most of which resolved a nagging problem. After analyzing the transcripts of these interviews, Dane developed a set of theoretical categories describing the varieties of reactions an epiphany might spark.

People generally perceive and analyze their epiphanies in similar ways, Dane found. He categorized these into four dimensions: a person's emotional reaction to the experience of the epiphany, the question of how the epiphany arose, the circumstances that preceded the insight and a person's observations about how ready they were to experience change through an epiphany.

The findings

The typical first reaction to an epiphany, Dane says, is a sudden and emotionally charged release from a problem or tension. We've all been there: a stressful work situation that seems to offer no way out, followed by a dazzling solution that appears from the clouds. It's that suddenness that leads to the second typical reaction: a sense of astonishment due to the nonconscious nature of the insight's arrival. Feeling dumbfounded for a prolonged time isn't useful, though, so we usually start examining the factors surrounding the epiphany, including our own readiness to change.

What does this imply for workplace? After all, not every problem can or even ought to be solved by epiphany. At the same time, Dane notes, epiphanies can provide critical impetus to move forward.

Interestingly, his findings hint that one can increase the chances of having an epiphany. Though further research is required, Dane concludes that epiphanies most commonly arrive when people are open to the prospect of experiencing a major change. When something is mentally constraining us, on the other hand, eureka moments keep their distance.

The conclusion

As a worker, Dane suggests, you can open space for epiphanies by being actively aware of your surroundings. Look closely at your workplace, your constellation of coworkers and your place within the system. Perceived mindfully, these details may set the stage for problem-solving in a less focused moment.

If you're a mentor or a supervisor hoping to spark epiphanies in your work team, try applying this principle at work: Rather than laying out specific targets and attacking them head-on, aim for an environment that allows for mindful engagement, one that includes the problems that feature in your long-term goals and resonate with your workers' concerns and interests. Cultivating this environment and granting workers time and space to wander through it may lead, like a divining rod, to fresh sources of wisdom.

------

This article originally appeared on Rice Business Wisdom.

Erik Dane is a distinguished associate professor of management (organizational behavior) at Jones Graduate School of Business at Rice University.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.